Active surveillance for prostate cancer

JAMA

Volumn 304, Issue 21, 2010, Pages 2411-2412

  Thompson, Ian M ^a   Klotz, Laurence ^b  

^a University of Texas Health Science Center at San Antonio   (United States)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVERSE OUTCOME; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; EDITORIAL; GLEASON SCORE; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; QUALITY ADJUSTED LIFE YEAR;

EID: 78649740508     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1761     Document Type: Editorial

References (10)

1. Etzioni R, Gulati R, Mariotto A. Overview of US prostate cancer trends in the era of PSA screening. In: Ankerst DP, Tangen CM, Thompson IM, eds. Prostate Cancer Screening. 2nd ed. New York, NY: Humana Press; 2009:3-14.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
3. Presti JC Jr. Biopsy strategies - how many and where? In: Jones JS, ed. Prostate Biopsy: Indications, Techniques, and Complications. New York, NY: Humana Press; 2008:165-178.
4. Powell IJ, Bock CH, Ruterbusch JJ, Sakr W. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol. 2010;183(5):1792-1796.
5. Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28(7):1117-1123.
6. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28(1):126-131.
7. Hayes JH, Ollendorf DA, Pearson SD, et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010;304(21):2373-2380.
8. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302(15):1685-1692.
9. Holmström B, Holmberg E, Egevad L, et al; National Prostate Cancer Register of Sweden. Outcome of primary vs deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study. J Urol. 2010;184(4):1322-1327.
10. Drago L, Nicola L, Mattina R, De Vecchi E. In vitro selection of resistance in Escherichia coli and Klebsiella spp at in vivo fluoroquinolone concentrations. BMC Microbiol. 2010;10:119.